ArticleEuropean journal of nuclear medicine and molecular imaging2016
(68)Ga-PSMA-HBED-CC PET/CT: where molecular imaging has an edge over morphological imaging.
Article in European journal of nuclear medicine and molecular imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Extraordinary Claims Don't always Require Extraordinary Evidence, but They Do Require Good Quality Evidence.Asian Pacific journal of cancer prevention : APJCP · 2019Article
- A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapy.European journal of nuclear medicine and molecular imaging · 2017Article
- Screening for Circulating Tumour Cells Allows Early Detection of Cancer and Monitoring of Treatment Effectiveness: An Observational StudyAsian Pacific journal of cancer prevention : APJCP · 2017Article
- PSMA expression by microvasculature of thyroid tumors - Potential implications for PSMA theranostics.Scientific reports · 2017Article
- The reconstruction algorithm used for [European journal of nuclear medicine and molecular imaging · 2017Article
- PSMA-PET for Lymph Node Detection in Recurrent Prostate Cancer: How do we use the Magic Bullet?Theranostics · 2017Article
- Impact ofEJNMMI research · 2016Article
- Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET/CT.European journal of nuclear medicine and molecular imaging · 2016Article
- Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA.Bioconjugate chemistry · 2016Article
Corrections and comments
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
26452581What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.